
Ben Zimmer, Priovant CEO
Roivant recently sold one spinout for billions. Is Priovant next?
When Roivant announced positive Phase 2 data of a key inflammatory drug back in April, the CEO of Priovant — the subsidiary in charge of development …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.